CLASS II ONGOING Drug recall · Reported 29 Oct 2025 · FDA Enforcement Report
Taoscare Motion Sickness Patches recalled by ibspot
ibspot is recalling Taoscare Motion Sickness Patches, Henan Xinyongtal Medical Technology., Ltd., Address: he, distributed in Virginia, Wyoming. The recall was initiated on 9 Oct 2025 and the FDA has classified it as Class II.
Check your package
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
Recall details
- Recall number
- D-0098-2026
- FDA event ID
- 97831
- Recalling firm
- ibspot, Elkins Park, PA
- Classification
- Class II
- Status
- Ongoing
- Recall initiated
- 9 Oct 2025
- FDA classified
- 23 Oct 2025
- Reported
- 29 Oct 2025
- Type
- Voluntary: Firm initiated
- Customers notified by
- Reason category
- Other Reasons
- Drug class
- Creams, Ointments & Gels
Timeline
| 9 Oct 2025 | Recall initiated by company | |
| 23 Oct 2025 | Classified by FDA | +14 days |
| 29 Oct 2025 | Published in enforcement report | +6 days |
Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.
Reason for recall
Marketed Without an Approved NDA/ANDA
Product as listed by the FDA
Taoscare Motion Sickness Patches 36-count box, Henan Xinyongtal Medical Technology., Ltd., Address: he nan sheng zhou kou shi huai yang xian gong ye yuan qu, X003SR097N
Where it was distributed
WY and VA
Questions about this recall
Why was it recalled?
Marketed Without an Approved NDA/ANDA
Which lots are affected?
none
Where was it sold?
WY and VA
What should I do if I have it?
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
What does Class II mean?
Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.
Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.